Kazia Therapeutics Annual Reports 2023

70 FINANCIAL REPORT NOTES TO THE FINANCIAL STATEMENTS CONTINUED 30 June 2023 Note 26. Remuneration of auditors During the financial year the following fees were paid or payable for services provided by BDO Audit Pty Ltd, the auditor of the Company: Consolidated 2023 2022 $ $ Audit services - BDO Audit Pty Ltd Audit or review of the financial statements 292,165 - Other services - BDO Audit Pty Ltd Comfort letter ATM 18,000 - 310,165 - Audit services - Grant Thornton Audit Pty Ltd Audit or review of the financial statements - 154,935 Other services - Grant Thornton Audit Pty Ltd Comfort letter ATM - 25,719 - 180,654 310,165 180,654 Comfort letter ATM refers to the fee in relation to Comfort Letter provided to Oppenheimer for ATM facility. Note 27. Related party transactions Parent entity Kazia Therapeutics Limited is the parent entity. Subsidiaries Interests in subsidiaries are set out in note 29. Key management personnel Disclosures relating to key management personnel are set out in note 25 and the remuneration report included in the directors’ report. Transactions with related parties There were no other transactions with KMP and their related parties. Receivable from and payable to related parties There were no trade receivables from or trade payables to related parties at the current and previous reporting date. Loans to/from related parties There were no loans to or from related parties at the current and previous reporting date. Terms and conditions All transactions were made on normal commercial terms and conditions and at market rates.

RkJQdWJsaXNoZXIy MjE2NDg3